Partner content/ Press releases/ R&D Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester Lisa Bedwell medicines discovery catapult, PET Imaging, R&D, radiochemistry, theranostics 0 Comment MDC relaunches Wolfson Radiochemistry facility Share X Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester https://pharmaphorum.com/partner-content/medicines-discovery-catapult-relaunches-wolfson-radiochemistry-facility-in-manchester/
Partner content/ Press releases First Psychiatry Consortium funded project announced for schizophrenia louise.bellamy@pharmaphorum.com medicines discovery catapult, Psychiatry Consortium, schizophrenia 0 Comment A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Share X First Psychiatry Consortium funded project announced for schizophrenia https://pharmaphorum.com/partner-content/first-psychiatry-consortium-funded-project-announced-for-schizophrenia/
Podcast/ R&D/ Views & Analysis/ Views and analysis The state of UK drug discovery: the pharmaphorum podcast Dominic Tyer artificial intelligence, cell models, Chris Molloy, clinical trials, Complex cell models, drug discovery, medicines discovery catapult, podcast 0 Comment The UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role Share X The state of UK drug discovery: the pharmaphorum podcast https://pharmaphorum.com/r-d/state-uk-drug-discovery-pharmaphorum-podcast/
Digital/ News/ News On-demand AI platform gets Innovate UK funding George Underwood AI, artificial intelligence, Chief.AI, Innovate UK, medicines discovery catapult 0 Comment Chief.AI and Medicines Discovery Catapult have been awarded £370,000 of funding from Innovate UK to develop a searchable Share X On-demand AI platform gets Innovate UK funding https://pharmaphorum.com/news/on-demand-ai-platform-gets-innovate-uk-funding/